Kardiyovasküler Sistem Değerlendirilmesi

De Gasperi, A., Spagnolin, G., Ornaghi, M., & Petrò, L. (2020). Preoperative cardiac assessment in liver transplant candidates. Best Practice & Research Clinical Anaesthesiology, 34(2), 173–184. https://arpi.unipi.it/bitstream/11568/1061176/1/YBEAN-D-20-3.pdf

Garg, A., & Armstrong, W. F. (2013). Echocardiography in liver transplant candidates. JACC: Cardiovascular Imaging, 6(1), 105–114. https://www.jacc.org/doi/full/10.1016/j.jcmg.2012.11.002

Brodosi, L., Petta, S., Petroni, M. L., & Marchesini, G. (2022). Management of diabetes in candidates for liver transplantation and in transplant recipients. Transplantation, 106(3), 455–462. https://journals.lww.com/transplantjournal/fulltext/2022/03000/Management_of_Diabetes_in_Candidates_for_Liver.15.aspx

Sastre, L., García, R., Viñals, C., & Amor, A. J. (2022). Results of a multidisciplinary strategy to improve the management of cardiovascular risk factors after liver transplantation. Liver Transplantation, 28(9), 1318–1325. https://aasldpubs.onlinelibrary.wiley.com/doi/pdf/10.1002/lt.26443

American Heart Association (2022). Emerging evidence on coronary heart disease screening in kidney and liver transplantation candidates: A scientific statement from the American Heart Association. Circulation, 145(5), e101–e120. https://www.ahajournals.org/doi/pdf/10.1161/CIR.0000000000001104

Izzy, M., Fortune, B. E., Serper, M., & Bhave, N. (2022). Management of cardiac diseases in liver transplant recipients: Comprehensive review and multidisciplinary practice-based recommendations. American Journal of Transplantation, 22(8), 2345–2360. https://www.sciencedirect.com/science/article/pii/S160061352300028X

Iaconi, M., Maritti, M., Ettorre, G. M., & Tritapepe, L. (2024). Echocardiographic evaluation in patient candidate for liver transplant: From pathophysiology to hemodynamic optimization. Journal of Anesthesia and Perioperative Care, 18(1), 45–55. https://link.springer.com/content/pdf/10.1186/s44158-024-00211-0.pdf

Wray, C. L. (2017). Advances in the anesthetic management of solid organ transplantation. Advances in Anesthesia, 35(1), 1–17. https://www.advancesinanesthesia.com/article/S0737-6146(17)30005-9/abstract

Anderson, L., Sanai, L., & Pace, N. A. (2001). Anesthesia for organ transplantation. In Transplantation Surgery (pp. 145–155). Springer. https://link.springer.com/chapter/10.1007/978-1-4471-3689-7_16

Savale, L., Benazzo, A., Corris, P., & Others. (2024). Transplantation, bridging, and support technologies in pulmonary hypertension. European Respiratory Journal, 64(4), Article 2401193. https://publications.ersnet.org/content/erj/64/4/2401193.full.pdf

De Wet, C., & Bowen, R. (2023). Anesthetic considerations in the LVAD candidate. In Transplantation and Mechanical Support for End-Stage Heart and Lung Disease (pp. 495–510). Wiley. https://onlinelibrary.wiley.com/doi/abs/10.1002/9781119633884.ch49

Barman, P. M., & VanWagner, L. B. (2021). Cardiac risk assessment in liver transplant candidates: Current controversies and future directions. Hepatology, 74(2), 456–468. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8220582/

Rachwan, R. J., Kutkut, I., & Hathaway, T. J. (2020). Postoperative atrial fibrillation and flutter in liver transplantation: An important predictor of early and late morbidity and mortality. Liver Transplantation, 26(11), 1378–1386. https://aasldpubs.onlinelibrary.wiley.com/doi/pdf/10.1002/lt.25631

Koshy, A. N., Chadha, R., & Pagano, G. (2024). Management of the high cardiac risk liver transplant candidate: Multidisciplinary best practices and recommendations. Liver Transplantation. https://journals.lww.com/lt/abstract/9900/management_of_the_high_cardiac_risk_liver.376.aspx

Yoon, U., Topper, J., & Goldhammer, J. (2022). Preoperative evaluation and anesthetic management of patients with liver cirrhosis undergoing cardiac surgery. Journal of Cardiothoracic and Vascular Anesthesia, 36(7), 2289–2295. https://www.sciencedirect.com/science/article/pii/S1053077020308168

Kim, W. R., Krowka, M. J., Plevak, D. J., Lee, J., & Rettke, S. R. (2000). Accuracy of Doppler echocardiography in the assessment of pulmonary hypertension in liver transplant candidates. Liver Transplantation, 6(4), 453–459. https://aasldpubs.onlinelibrary.wiley.com/doi/pdf/10.1053/jlts.2000.7573

Pilatis, N. D., Jacobs, L. E., Rerkpattanapipat, P., & Others. (2000). Clinical predictors of pulmonary hypertension in patients undergoing liver transplant evaluation. Liver Transplantation, 6(1), 134–140. https://aasldpubs.onlinelibrary.wiley.com/doi/pdf/10.1002/lt.500060116

Doytchinova, A. T., Feigenbaum, T. D., & Others. (2019). Diagnostic performance of dobutamine stress echocardiography in end-stage liver disease. JACC: Cardiovascular Imaging, 12(6), 1105–1115. https://www.jacc.org/doi/full/10.1016/j.jcmg.2018.10.031

Agrawal, A., Jain, D., Dias, A., & Jorge, V. (2018). Real world utility of dobutamine stress echocardiography in predicting perioperative cardiovascular morbidity and mortality after orthotopic liver transplantation. Korean Circulation Journal, 48(10), 828–837. https://synapse.koreamed.org/upload/synapsedata/pdfdata/0054kcj/kcj-48-828.pdf

Reddy, S. T., Thai, N. L., Oliva, J., & Tom, K. B. (2018). Cardio‐hepatic risk assessment by CMR imaging in liver transplant candidates. Clinical Transplantation, 32(6), Article e13229. https://onlinelibrary.wiley.com/doi/abs/10.1111/ctr.13229

Sannani, A., Levine, A., & Gupta, C. A. (2018). Diagnosis, treatment, and management of orthotopic liver transplant candidates with portopulmonary hypertension. Cardiology in Review, 26(4), 185–192. https://journals.lww.com/cardiologyinreview/fulltext/2018/07000/Diagnosis,_Treatment,_and_Management_of_Orthotopic.2.aspx

DuBrock, H. M., & Krowka, M. J. (2019). Pulmonary evaluation of liver transplant candidates. In Critical Care for Potential Liver Transplant Candidates (pp. 15–30). Springer. https://link.springer.com/chapter/10.1007/978-3-319-92934-7_2

Jabagi, H., Mielniczuk, L. M., Liu, P. P., & Ruel, M. (2019). Biomarkers in the diagnosis, management, and prognostication of perioperative right ventricular failure in cardiac surgery—are we there yet? Journal of Clinical Medicine, 8(4), Article 559. https://www.mdpi.com/2077-0383/8/4/559/pdf

Lentine, K. L., Costa, S. P., Weir, M. R., Robb, J. F., Fleisher, L. A., et al. (2012). Cardiac disease evaluation and management among kidney and liver transplantation candidates: A scientific statement from the American Heart Association. Circulation, 126(5), 617–663. https://www.ahajournals.org/doi/pdf/10.1161/cir.0b013e31823eb07a

Raval, Z., Harinstein, M. E., Skaro, A. I., Erdogan, A., DeWolf, A. M., et al. (2011). Cardiovascular risk assessment of the liver transplant candidate. Journal of the American College of Cardiology, 58(3), 223–231. https://www.jacc.org/doi/full/10.1016/j.jacc.2011.03.026

Mirabella, S., Younes, R., Di Stefano, C., Vanni, E., & Others. (2018). Risk factors for arterial hypertension after liver transplantation. Journal of the American College of Cardiology, 71(11), 1117–1126.

Henrohn, D., Sandqvist, A., Hedeland, M., & Others. (2012). Acute haemodynamic response in relation to plasma vardenafil concentrations in patients with pulmonary hypertension. British Journal of Clinical Pharmacology, 73(1), 109–117. https://bpspubs.onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2125.2012.04303.x

Ghofrani, H. A., Voswinckel, R., Reichenberger, F., & Others. (2004). Hypoxic pulmonary vasoconstriction and oxygenation responses to three different phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension: A randomized prospective study. Journal of the American College of Cardiology, 45(9), 1424–1431. https://www.jacc.org/doi/full/10.1016/j.jacc.2004.06.060

Williamson, D. J., Wallman, L. L., Jones, R., & Keogh, A. M. (2000). Hemodynamic effects of bosentan, an endothelin receptor antagonist, in patients with pulmonary hypertension. Circulation, 102(4), 411–418. https://www.ahajournals.org/doi/abs/10.1161/01.CIR.102.4.411

Pehlivan, Y., Dokuyucu, R., Demir, T., Kaplan, D. S., & Koc, I. (2014). Palosuran treatment effective as bosentan in the treatment model of pulmonary arterial hypertension. Inflammation, 37(5), 1505–1514. https://link.springer.com/article/10.1007/s10753-014-9855-8